PatientsLikeMe ™
Already a member? Sign in
Updating results…
Clinical Trial Treatment Report
Category: Others
Most Popular Types: BG-12, Experimental Drug, CoQ10 Study (Show all)
Generic Name: Clinical Trial
See also: ALS Phase 1 Study NP001, ALS Phase 2B Study CK-2017357, ALS Phase 2 Study Lithium Carbonate, ALS Phase 2 Study NP001, ALS Phase 3 Study Ceftriaxone, ALS Phase 3 Study Dexpramipexole (KNS-760704), ALS Phase 3 Study TRO19622, Epilepsy Phase 3 Study Retigabine IR, FTY720 (Fingolimod) Clinical Trial, Gc Protein-derived Macrophage Activating Factor (GcMAF), Kidney Transplant Phase 3 Belatacept BENEFIT, Mesothelioma Lung Cancer Phase 3 Study Vorinostat, MS HOPE Study Apoaequorin, MS Phase 2 Study ACT-128800, MS Phase 2 Study Nerispirdine (HP184), MS Phase 2 Study ONO-4641, MS Phase 3 Fingolimod FREEDOMS, MS Phase 3 Fingolimod TRANSFORMS, MS Phase 3 Study CombiRx, MS Phase 3 Study DECIDE, MS Phase 3 Study Fingolimod, MS Phase 3 Study Fingolimod FREEDOMS II, MS Phase 3 Study Laquinimod, MS Phase 3 Study Laquinimod BRAVO, MS Phase 3 Study Teriflunomide (HMR1726) TOWER, Multiple Myeloma Phase 2 Study Carfilzomib, Parkinson's Phase 3 Study CoQ10 QE3, Parkinson's Phase 3 Study Creatine, Parkinson's Phase 3 Study IPX066 APEX-PD, Parkinson's Phase 3 Study Safinimide, Plaque Psoriasis Phase 3 Study CP-690,550, RA Phase 2-3 Study Tasocitinib (CP-690,550)
What is Clinical Trial?
Clinical trials determine if new research treatments effectively treat or even cure medical conditions. A comprehensive registry of federally and privately supported clinical trials conducted in the United States and around the world is available at the web site ClinicalTrials.gov.
Reported Purpose & Efficacy
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Fibromyalgia | 7 | 0 | |||||
| MS (Multiple Sclerosis) | 4 | 0 | |||||
| Other | 4 | 1 |
|
||||
| Parkinson's Disease | 2 | 0 | |||||
| Increase effect of another treatment | 2 | 0 | |||||
| Chronic Fatigue Syndrome | 2 | 0 |
See all 34 patients currently using Clinical Trial
Mouse over the table for more information
Reported Side Effects
Commonly reported side effects, conditions, and hospitalizations associated with Clinical Trial
| Pain | 1 | |
|---|---|---|
| Anxious mood | 1 | |
| Dizziness | 1 | |
| Agitation | 1 | |
| Sex drive (libido) increased | 1 | |
| Hospitalization | 1 |
Reported Schedules
Frequently reported dosages based on patients currently using Clinical Trial. See all 27 dosages ►
Reported Stop Reasons
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Expense | 2 |  |
|
| Personal research | 2 | |
|
| Did not seem to work | 1 | |
|
| Other | 1 | |
|
| Course of treatment ended | 1 | |
Reported Duration See details about how long patients take this treatment ▼
Reported Adherence, Burden & Cost See details from patient evaluations ▼
Adherence
Taking treatment as prescribed
Adherence of Clinical Trial
Always |
3 | 75% |
|
|---|---|---|---|
Usually |
1 | 25% |
|
Sometimes |
0 | 0% |
|
Never |
0 | 0% |
|
Burden
Difficulty being on treatment
Burden of Clinical Trial
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
1 | 25% |
|
A little |
0 | 0% |
|
Not at all |
3 | 75% |
|
Cost
Paid out of pocket
Cost of Clinical Trial
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
1 | 33% |
|
$50-99 |
0 | 0% |
|
$25-49 |
0 | 0% |
|
< $25 |
2 | 67% |
|
Patient Evaluations
See all 4 patient evaluations
-
-
- dhaniboi
- 12 mg daily
- since Feb 21, 2011
-
Efficacy
Moderate
for Epilepsy
-
Side Effects
Mild
- See full evaluation
See all 4 patient evaluations
Report created on May 28, 2012.